Retina/Vitreous

Top Story

Ziv-aflibercept improves visual acuity, macular thickness in refractory DME

June 23, 2017

Patients with refractory diabetic macular edema treated with ziv-aflibercept experienced improved visual acuity and macular thickness, with no adverse ocular or systemic side effects reported in the retrospective case series.

The case series included 34 eyes of 26 patients who had been switched to Zaltrap (ziv-aflibercept, Sanofi-Aventis/Regeneron) to treat refractory DME. All patients had previously received injections of anti-VEGF therapy. Patients received an average of 2.03 injections of ziv-aflibercept after switching treatments.

Publication Exclusive

PUBLICATION EXCLUSIVE: Young woman who went blind in one eye presents years later with symptoms in fellow eye

June 22, 2017
A 21-year-old Hispanic woman presented to the University of New Mexico with a 1-month history of worsening flashes of light and scotomas in her left superior field of…

Marketing authorization application filed in Europe for Durasert 3-year uveitis treatment

June 22, 2017
A marketing authorization application has been filed to the European Medicines Agency for the approval to market Durasert 3-year treatment for posterior segment uveitis…
In the Journals

Lampalizumab reduces geographic atrophy lesion progression

June 21, 2017
Monthly lampalizumab, a potential therapy for patients with geographic atrophy secondary to age-related macular degeneration, reduced lesion area progression by 20%…
CME

Best of Retina Forum® 2016 - Diabetic Retinopathy: A Revolution in Treatment Options

This activity is supported by educational grants from Carl Zeiss Meditec, Inc. and Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy (DR) is an insidious, progressive disease. Diabetic macular edema (DME), which can occur at any…
More »
Video
Meeting News

VIDEO: Actemra shows potential as giant cell arteritis treatment

May 9, 2017
More »
Featured
Optometry's Meeting

Optometry's Meeting

Video
Meeting News

VIDEO: Ozurdex reduces ischemia in diabetic retinopathy in pilot study

May 24, 2017
More »
In the Journals

Ziv-aflibercept improves visual acuity, macular thickness in refractory DME

June 23, 2017
Patients with refractory diabetic macular edema treated with ziv-aflibercept experienced improved visual acuity and macular thickness, with no…

Publication Exclusive

PUBLICATION EXCLUSIVE: Young woman who went blind in one eye presents years later with symptoms in fellow eye

June 22, 2017
A 21-year-old Hispanic woman presented to the University of New Mexico with a 1-month history of worsening flashes of light and scotomas in her left…

Marketing authorization application filed in Europe for Durasert 3-year uveitis treatment

June 22, 2017
A marketing authorization application has been filed to the European Medicines Agency for the approval to market Durasert 3-year treatment for…

In the Journals

Lampalizumab reduces geographic atrophy lesion progression

June 21, 2017
Monthly lampalizumab, a potential therapy for patients with geographic atrophy secondary to age-related macular degeneration, reduced lesion area…

Meeting NewsVideo

VIDEO: Brimonidine investigated for preserving vision in glaucoma and retina disease

June 21, 2017
BALTIMORE — At the Association for Research in Vision and Ophthalmology meeting here, James Burke, PhD, of Allergan, discusses research into…

Neurotech’s macular telangiectasia treatment sees positive phase 2 results

June 20, 2017
A phase 2 trial of NT-501 found the therapy had a beneficial effect in patients with macular telangiectasia type 2, according to a press release from…

Meeting News

Sildenafil shown to expand choroidal vessels in patients with AMD

June 20, 2017
Researchers found that sildenafil citrate increases choroidal thickness in eyes with both wet and dry age-related macular degeneration. Vuong and…

Perspective

Novartis’ RTH258 for wet AMD meets endpoints in phase 3 trials

June 20, 2017
RTH258 for wet age-related macular degeneration met its primary and key secondary endpoints in two phase 3 studies, according to a Novartis press…

Meeting News

Evaluate hemorrhages, microaneurysm with UWFI to determine DR progression risk

June 20, 2017
More peripheral and total microaneurysms were associated with increased diabetic retinopathy progression over 4 years in patients with mild to…

FDA approves ReNeuron’s cryopreserved formulation of retinal stem cell therapy candidate

June 20, 2017
The FDA has approved the cryopreserved formulation of ReNeuron Group’s human retinal progenitor cell therapeutic candidate, according to a…

More Headlines »
Advertisement
Advertisement